期刊文献+

Bcl-2及Bax基因蛋白在听神经瘤组织中的表达及意义 被引量:1

Expression of Bcl-2/Bax Oncogene Protein in Acoustic Neuroma Tissues and Its Significance
原文传递
导出
摘要 目的 :评价Bcl 2及Bax基因蛋白在听神经瘤组织中的表达及意义。方法 :取库存石蜡包埋组织标本 ,40例听神经瘤分作复发组、囊变组及对照组 ,采用SABC法免疫组化半定量检测Bcl 2及Bax蛋白在听神经瘤组织中的表达。结果 :Bcl 2阳性者 2 7例 ,多见于AntoniA区 ;Bax阳性者 2 6例 ,多见于AntoniB区。不同组间Bcl 2与Bax表达的相对构成有差别 (χ2 =6 64 ,P <0 0 5 )。结论 :Bcl 2 Aim:To evaluate the level of two kinds of oncogene proteins Bcl 2/Bax expression within paraffin embedded acousitc neuroma (AN) tissues and its significance. Methods:40 cases of selected archival AN materials were classified as recurrence (10 cases), cystic degeneration (10 cases) and common contrast (20 cases). 3 groups based on the different clinical biological behavior of ANs separately, and were detected for Bcl 2/Bax protein expression by SABC immunohistochemical technique and semi quantitative scales.Results:Of all cases, 27 were positive for Bcl 2 (67 5%), mainly within Antoni A zone and stained heavily and widespread; 26 were positive for Bax (65%), major within Antoni B zone and stained lightly and scattered. According to the relative expression level (REL) of Bcl 2/Bax, there were differences with the REL construction rate of Bcl 2 versus Bax proteins among groups (χ 2=6 64, P <0 05), that is, Bcl 2>Bax were recurrence>common contrast>cystic degeneration. Conclusion:There is an active expression of apoptosis related protein within paraffin embedded AN tissues. Singly, neither Bcl 2 nor Bax is related to clinical biological behavior of ANs. The construction rate of Bcl 2/Bax REL, however, would be related to it.
出处 《中国临床神经科学》 2001年第1期38-40,共3页 Chinese Journal of Clinical Neurosciences
关键词 细胞凋亡 癌基因蛋白 听神经瘤 生物学行为 BCL-2 BAX acoustic neuroma oncogene protein apoptosis biological behavior
  • 相关文献

参考文献1

  • 1Satoshi Nakasu,Yoko Nakasu,Hirofumi Nioka,Masayuki Nakajima,Jyoji Handa. bcl-2 protein expression in tumors of the central nervous system[J] 1994,Acta Neuropathologica(6):520~526

同被引文献26

  • 1Twist EC,Ruttledge MH,Marylene Rousseau,et al.The neurofibromatosis type 2 gene in inactivated in schwannomas[J].Hum Mol Genet,1994,3(1):147-151.
  • 2Irving RM,Moffat DA,Hardy DG,et al.Somatic NF2 gene mutation in familial and non-familial vestibular schwannoma[J].Hum Mol Genet,1994,3(2):347-350.
  • 3Sainz J,Figueroa K,Baser ME,et al.Idertification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannoma[J].Hum Genet,1996,97(1):121-123.
  • 4Lekanne Deprez RH,Bianchi AB,Groen NA,et al.Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas[J].Am J.Hum Genet,1994,54(6):1022-1029.
  • 5Irving RM,Moffat DA,Hardy DG,et al.A molecular,clinical,and immunohistochemical study of vestibular schwannoma[J].Otolaryngol Head Neck Surg,1997,116(4):426-430.
  • 6Faudoa R,Xue Z,Lee F,et al.Detection of novel NF2 mutations by an RNA mismatch cleavage method[J].Hum Mutation,2000,15(5):474-478.
  • 7Sainz J,Figueroa K,Baser ME,et al.High frequency of nonsense mutation in the NF2 gene caused by C to T transitions in five CGA codons[J].Hum Mol Genet,1995,4(1):137-139.
  • 8De Vitis LR,Tedde A,Vitelli F,et al.Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin[J].Hum Genet,1996,97(5):638-641.
  • 9Kluwe L,Bayer S,Baser ME,et al.Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes[J].Hum Genet,1996,98(5):534-538.
  • 10Evans DG,Trueman L,Wallace A,et al.Genotype/phenotype correlations in type 2 neurofibromatosis (NF2):evidence for more severe disease associated with truncating mutations[J].J Med Genet,1998,35:45-455.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部